The entire market is down today. BTC is around $75,700, down 6% over 24 hours, while ETH is down 7.4%, with over $1 billion in liquidations across the market. Yet one unexpected name is near the top of the gainers list: INJ, trading at around $8.05–$8.35, up about 3% against the trend.

Its rise isn’t because its fundamentals suddenly improved overnight. It’s because it just got a new ticket yesterday: Nasdaq approved the listing of Canary’s staking-based INJ ETF (INJC). Here’s the bottom line: the real value of this ticket isn’t the word “approved,” but whether the numbers add up in three areas—yield, liquidity, and demand. If they don’t, the ticket is just a brief taste of a limit-up rally.

First, let’s lay out the full picture.

On November 3, Canary filed a Form 8-A with the SEC, and Nasdaq approved INJC for listing. On November 4, the final prospectus was released and the fund was established. On November 5, Injective officially announced the listing; INJ led the CoinDesk 100 that day, trading at around $8.16, up about 10% over 24 hours. From its November 3 low of $6.82, it gained about 22% in three days.

The product structure is key. Let’s break it down:

First, it directly holds spot INJ—not futures or a synthetic index. Under normal circumstances, at least 90% of its holdings are staked to earn on-chain rewards; the remaining roughly 10% is held as a buffer for redemptions and expenses. BitGo provides custody, Luganodes runs the validator nodes, and U.S. Bank manages the cash.

Second, the fees aren’t cheap: a 1.10% annual sponsor fee, plus 30% of total staking rewards distributed among the sponsor, staking service providers, and custodian. First, 30% of the rewards are taken; then the annual fee is deducted. Only what’s left goes toward net asset value.

Third, staked INJ has a 21-day unbonding period—the delegated tokens can’t be transferred or withdrawn during those 21 days.

Fourth, the Injective Foundation said it plans to subscribe for up to $15 million in seed shares. INJ’s market cap is around $820 million, so $15 million is about 1.8%—not a small amount.

This isn’t the first staking ETF. In July 2025, REX-Osprey’s SOL Staking ETF (SSK) launched, attracting $12 million in inflows and trading $33 million on its first day. In March this year, BlackRock’s ETH Staking ETF launched. On September 29, Bitwise’s NEAR ETF began trading on NYSE Arca. Staking inside ETFs is moving from “one-off” to “assembly line.”

My framework for assessing this is what I call “three ledgers.”

First, the return ledger. When you buy INJC, you’re buying two things: changes in INJ’s price and net staking rewards. The costs are certain—an annual fee of 1.10% plus a 30% cut of rewards. The returns are uncertain: annualized staking yields fluctuate with network conditions, and the prospectus hasn’t disclosed the current net yield. It’s important to ask the right question: not “Does it earn staking rewards?” but “How much is left after fees?” If the on-chain staking yield is only in the single digits, taking off 30% and then the annual fee could leave a net yield so thin it’s negligible. At that point, what you’re really buying is just a slightly more expensive spot ETF.

Second, the liquidity ledger. ETF shares can be bought and sold at any time during trading hours, but 90% of the tokens behind them are locked in a 21-day unbonding period. Normally, that’s no problem; the 10% buffer should be enough for routine creations and redemptions. But if there’s a wave of concentrated redemptions—for example, if INJ plunges and everyone wants out at once—the prospectus doesn’t provide stress-test figures showing whether the buffer would be enough. That’s the market’s first test. The price of staking rewards is giving up some liquidity. Whether that trade-off is worth it won’t be clear until the first wave of redemptions.

Third, the demand ledger. Approval to list doesn’t mean money will flow in. SSK’s $12 million in first-day inflows is a point of reference, but SOL and INJ are in completely different weight classes: INJ’s market cap is around $820 million, and a $15 million seed investment already amounts to 1.8%. For a small-cap coin, ETF creations and redemptions themselves could amplify volatility—inflows mean buying, outflows mean selling. The channel has no direction of its own; it only amplifies the direction. So what’s really worth watching isn’t “approval,” but actual flows in the first few weeks: beyond the seed investment, will a second and third wave of money come in?

Let’s honestly lay out the risks and counterevidence:

First, differences in terminology. Exchange approval for listing and the SEC’s registration becoming effective are two separate steps. On the listing day, some reports still noted that the S-1’s effective status needed to be confirmed. I’m relying on Nasdaq’s 8-A filing, the prospectus, and Injective’s official information—not an announcement post. Check the exchange’s latest disclosures for the trading status.

Second, the price has already moved in anticipation. INJ is up about 22% from its November 3 low. Some technical analysis indicates that the RSI is overbought and the moving-average death cross remains unresolved, so the rally hasn’t been confirmed. Today, while the broader market fell 6%, INJ still rose 3%—that was driven by news, not by a trend.

Third, staking rewards aren’t guaranteed and fluctuate with network conditions. During the 21-day unbonding period, you’re fully exposed to price swings. The ETF saves you the hassle of managing a wallet; it doesn’t shield you from volatility.

Fourth, don’t mistake “first” for a moat. INJC is the first INJ staking ETF, but the staking ETF field is getting more crowded: SOL, ETH, and NEAR are all in the mix. How long the first-mover advantage lasts depends on flows, not the name.

To sum up: what staking ETFs really change isn’t INJ’s price. It’s that “yield” has, for the first time, been packaged into something you can buy and sell in a brokerage account. The package itself doesn’t generate yield; it just makes yield easier to buy—and things that are easy to buy are often easier to sell, too.

I’ll leave you with a real question: If you could avoid managing your own wallet and automatically earn staking rewards, but had to pay a 1.10% annual fee plus a 30% cut of rewards, would you buy this package or stake on your own? Why? Let’s talk in the comments.

One article every day, each one taking a deep dive into a single topic. Yesterday, we broke down the three numbers behind HYPE’s unlock. Today, we looked at the three ledgers for staking ETFs. See you tomorrow.

No hype, just the numbers.

$INJ

#质押ETF #ETF